Dover Hits $8.1 Billion Revenue Driven by Biopharma and Data Center Cooling
Dover CorporationDescription
What this story covers
Dover Corporation’s 2025 10-K reveals a strategic shift toward high-margin sectors like biopharma and data centers, achieving $8.1 billion in revenue. Despite divestiture-related earnings fluctuations, record margin expansion and a 70-year dividend streak highlight the company's industrial resilience.
Story snapshot
CompanyDover Corporation
TickerDOV
VariantStandard detailed
Duration11:00
Filing type10-K
PeriodAnnual 2025
IndustryIndustrials & Manufacturing
Accession0000029905-26-000009
Sources1
Full Story Script
Content not available for this story.